Finance

Beta
Lists
ANTX:NASDAQ
AN2 Therapeutics Inc
$4.33
-2.91%
(-0.13) 1D
May 29, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANTX...
Open
$4.43
High
$4.65
Low
$4.28
Mkt. cap
155.95M
Avg. vol.
253.72K
Volume
112.29K
52-wk high
$6.91
52-wk low
$1.00
EPS
-$1.10
Beta
-0.95
Shares outstanding
36.02M
No. of employees
21
Open
$4.43
High
$4.65
Low
$4.28
Mkt. cap
155.95M
Avg. vol.
253.72K
Volume
112.29K
52-wk high
$6.91
52-wk low
$1.00
EPS
-$1.10
Beta
-0.95
Shares outstanding
36.02M
No. of employees
21
News stories
From sources across the web
About AN2 Therapeutics Inc
CEO-
Employees21
Founded2017
HeadquartersMenlo Park, California, United States
SectorPharmaceutical industry
Websitean2therapeutics.com
Last report
May 11, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.29 / -$0.23
-26.09%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.20M
7.00M
6.88M
6.74M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.02M
3.04M
2.44M
3.81M
Operating expense
7.22M
10.04M
9.32M
10.55M
Total operating expenses
7.22M
10.04M
9.32M
10.55M
Operating income
-7.22M
-10.04M
-9.32M
-10.55M
Other non operating income
-
-
1.00K
-
EBT including unusual items
-6.46M
-9.35M
-8.71M
-10.03M
EBT excluding unusual items
-6.46M
-9.35M
-8.71M
-10.03M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6.46M
-9.35M
-8.71M
-10.03M
Net profit margin
-
-
-
-
Earnings per share
-0.21
-0.31
-0.29
-0.29
Interest and investment income
754.00K
687.00K
605.00K
523.00K
Interest expense
-
-
-
-
Net interest expenses
754.00K
687.00K
605.00K
523.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer